Graham J, Earnshaw S, Lim J, Luthra R, Borker R. Cost-effectiveness of afatinib versus erlotinib in the first-line treatment of patients with metastatic non-small cell lung cancer with EGFR Exon 19 deletion mutations. JCP. 2016 May;2(4):31-9.
Merrill RM, Madanat H, Kelley AT, Layton JB. Nurse and physician patient counseling about tobacco smoking in Jordan. Promot Educ. 2008 Sep;15(3):9-14. doi: 10.1177/1025382308095649